AristaMD

AristaMD

AristaMD was founded to solve the persistent breakdown between primary and specialty care. Led by CEO Keith Pinter, a growth-oriented change leader with two decades in healthcare provider and technology sectors, the company equips PCPs with a suite called SpecialtyCare360. The platform spans Care Delivery, Care Support, Care Design, and Performance Oversight, aiming to reduce cost and improve outcomes at the point of referral. Key investors and board members connect the firm to Ascension Ventures, MemorialCare Innovation Fund, and Valeo Ventures, anchoring AristaMD inside large provider-aligned capital networks. The firm's strategy targets the clinical services layer rather than pure software licensing. Its flagship eConsult product routes patient cases to contracted specialists in cardiology, rheumatology, and musculoskeletal care, among others. Nurse managers use evidence-based care plans to determine whether a patient needs an eConsult, a video visit, or an in-person appointment. This care-navigation component is paired with patient support and health coaching. Confirmed partners include Ascension Ventures and MemorialCare Innovation Fund. Geographic deployment extends across the United States, with trust built among thousands of physicians nationwide. Team scale and adjacent vehicles remain largely undisclosed beyond the executive leadership tier. Chief Medical Officer Julia Jezmir, a primary care physician with a value-based-care background, joined from a digital health role, while CFO Mike Gierut arrived from a senior finance post in the healthcare industry. The board includes Don Calcagno, former Chief Population Health Officer at Advocate Health, and Dr. Ali Khan, Chief Medical Officer for Medicare Programs at Aetna. No dedicated philanthropic foundation or real-asset arm has been identified. No recent fundraising round or deployment figure has been made public as of May 2026. AristaMD’s structural differentiator lies in pairing an NCQA-conforming, contracted specialist panel with nurse-led care routing. This embeds clinical decision-making into the referral process itself, rather than merely facilitating a telehealth appointment. The model sells directly into risk-bearing organizations — health systems, payers, and value-based care groups — that are financially incented to avoid unnecessary specialty visits. With board ties to Ascension Ventures, MemorialCare, and Aetna’s Medicare leadership, the governance structure reflects a tight alignment with the organizations that consume and fund specialty-care diversion.